Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Government of the United States”

99 pharma patents match "The Government of the United States" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 99
Index total 30,257
Page 2 / 5

Quick answer

This filtered view shows 99 pharmaceutical patents matching "The Government of the United States" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

99 results for “The Government of the United States” · 30,257 patents in full index Clear search

  1. US 11440951

    Therapeutic antibodies to Marburg virus

    The Government of the United States, as represented by the Secretary of the Army · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  2. US 11389400

    Aerosilization of stem cells or stem cell derivatives for pulmonary delivery

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  3. US 11345653

    Compositions and methods for reactivating cholinesterases

    The Government of the United States, as represented by the Secretary of the Army · Granted May 31, 2022 · Expires May 26, 2042

    granted

  4. US 11339387

    Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted May 24, 2022 · Expires May 19, 2042

    granted

  5. US 11332722

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  6. US 11285204

    Tobamovirus-based virus-like particles and vaccines

    THE GOVERNMENT OF THE UNITED STATES, AS REPRESEN · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  7. US 11191824

    Method of purifying virus-like-particles

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  8. US 11160859

    Materials and methods for respiratory disease control in canines

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  9. US 11155834

    Sin Nombre virus full-length M segment-based DNA vaccines

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  10. US 11154608

    Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  11. US 11065332

    Combination therapy of immunotoxin and checkpoint inhibitor

    The Government of The United States as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  12. US 11053285

    Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp120 immunogens and methods of use

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  13. US 11045558

    RPGR gene therapy for retinitis pigmentosa

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  14. US 11041008

    Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  15. US 11033615

    Zika virus vaccine and methods of production

    The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  16. US 11028152

    Single domain antibodies to Chikungunya virus

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  17. US 11013791

    NYVAC-based plasmodium malaria vaccine

    The Government of the United States, as represented by the Secretary of the Army · Granted May 25, 2021 · Expires May 20, 2041

    granted

  18. US 11008564

    Processing engineered FMDV P1 polypeptide using an alternative TEV protease

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted May 18, 2021 · Expires May 13, 2041

    granted

  19. US 10961261

    Oxaborole analogs and uses thereof

    The Government of the United States, as represented by the Secretaryof the Army · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  20. US 10961298

    Monoclonal antibodies for treatment of microbial infections

    The Government of the United States, represented by the Secretary of the Army · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  21. US 10934360

    Human monoclonal antibodies against EPHA4 and their use

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  22. US 10898583

    Harnessing quantum dots to study, visualize, and promote immune tolerance

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  23. US 10894816

    Use of IL-15 to increase thymic output and to treat lymphopenia

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  24. US 10888558

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.